Recent analyses of DDIT4 in several cancer types have shown that high expression of this gene is associated with poor prognosis in several hematological and solid tumors, such as acute myeloid leukemia (67), breast cancer (68) and lung cancer (69). Here, DDIT4 is linked to breast cancer.